RxDoctor Payments Data

Rachel Sjostrom, APRN

Family · Bradenton, FLNPI 1659026573

Payments from drug & device makers

$395in general payments, 2019–2025

Across 21 payments — averaging $18.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$92
  • Novo Nordisk$55
  • Amgen$50
  • GSK$45
  • Novartis$39
  • Lilly USA, LLC$29
  • plus $85 from 4 others

What the payments were for

  • Food & beverage$395100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$395 in reported general payments places this provider in the 50th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$88,746
Medicare patients
274
Services billed
1,345

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban12$4,805
Losartan Potassium14$301
Torsemide14$192
Levothyroxine Sodium18$187

Paid to pharmacies, not to this prescriber.

Other family in Bradenton

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →